Prelude Capital Management’s Cano Health, Inc. CANO Stock Holding History

Prelude Capital Management’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-846	Closed	-$21.5K	–	1485
2023 Q3	$21.5K	Buy	846 +581	+219%	+$47.8K	﹤0.01%	1068
2023 Q2	$36.9K	Buy	265 +142	+115%	+$18.2K	﹤0.01%	989
2023 Q1	$11.2K	Sell	123 -520	-81%	-$70.6K	﹤0.01%	1061
2022 Q4	$88K	Buy	643 +361	+128%	+$122K	﹤0.01%	1092
2022 Q3	$244K	Buy	+282	New	+$177K	0.01%	981
2021 Q4	–	Sell	-345	Closed	-$437K	–	2339
2021 Q3	$437K	Buy	+345	New	+$418K	0.01%	962
2021 Q2	–	Sell	-200	Closed	-$265K	–	2064
2021 Q1	$265K	Buy	+200	New	+$283K	0.01%	1203

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prelude Capital Management's CANO Position: Q4 2023 in Review

Prelude Capital Management sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 846 shares — an estimated $21.5K sold.

Prelude Capital Management first reported a position in CANO in Q1 2021 and held it in 7 quarters. The position peaked at $437K in Q3 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

Prelude Capital Management reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
Prelude Capital Management sold 846 Cano Health, Inc. shares in Q4 2023, an estimated $21.5K.
Prelude Capital Management first reported a position in Cano Health, Inc. in Q1 2021 and held it in 7 quarters.
Prelude Capital Management's Cano Health, Inc. position peaked at $437K in Q3 2021.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.